Two Sigma Investments, LP Replimune Group, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 212,586 shares of REPL stock, worth $2.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

212,586

Previous 179,240 18.6%

Holding current value

$2.61 Million

Previous $1.96 Million 31.06%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.54 - $14.93 $351,466 - $497,855	33,346 Added 18.6%	212,586 $2.57 Million
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $224,740 - $311,969	-27,780 Reduced 13.42%	179,240 $1.96 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $510,123 - $963,226	-101,821 Reduced 32.97%	207,020 $1.86 Million
Q1 2024 May 15, 2024	BUY	$6.87 - $9.31 $1.34 Million - $1.81 Million	194,659 Added 170.48%	308,841 $2.52 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $770,728 - $1.85 Million	114,182 New	114,182 $962,000
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $1.14 Million - $1.75 Million	-72,813 Reduced 28.56%	182,111 $4.23 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $4.46 Million - $7.42 Million	254,924 New	254,924 $4.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $381,061 - $516,631	24,427 Added 40.57%	84,634 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $2.11 Million - $3.17 Million	-158,585 Reduced 72.48%	60,207 $1.05 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $1.86 Million - $3.63 Million	122,084 Added 126.24%	218,792 $3.72 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $240,262 - $323,594	-9,448 Reduced 8.9%	96,708 $2.62 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $1.47 Million - $2.01 Million	-50,732 Reduced 32.34%	106,156 $3.15 Million
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $6.04 Million - $8.34 Million	-211,807 Reduced 57.45%	156,888 $6.03 Million
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $1.2 Million - $1.81 Million	39,763 Added 12.09%	368,695 $11.2 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $6.23 Million - $14 Million	265,097 Added 415.28%	328,932 $12.5 Million
Q3 2020 Nov 16, 2020	BUY	$18.85 - $27.0 $961,500 - $1.38 Million	51,008 Added 397.66%	63,835 $1.47 Million
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $125,191 - $332,860	12,827 New	12,827 $319,000
Q1 2020 May 15, 2020	SELL	$8.9 - $19.08 $305,554 - $655,054	-34,332 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $398,594 - $590,853	34,332 New	34,332 $493,000

Others Institutions Holding REPL

# of Institutions

161

Shares Held

74.9M

Call Options Held

38.4K

Put Options Held

43.7K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $606M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Replimune Group, Inc. Transaction History